-
PI3K's two heavens of ice and fire: delisting in Europe and the United States, and listing in China
Time of Update: 2023-01-06
In 2018, Secura's PI3K inhibitor, Duvelisib, was fully approved by the FDA for the treatment of adult patients with relapsed/refractory CLL/SLL who have received at least two upfront therapies, and also received accelerated approval for the third-line treatment of follicular lymphoma.
-
PI3K's two heavens of ice and fire: delisting in Europe and the United States, and listing in China
Time of Update: 2023-01-06
In 2018, Secura's PI3K inhibitor, Duvelisib, was fully approved by the FDA for the treatment of adult patients with relapsed/refractory CLL/SLL who have received at least two upfront therapies, and also received accelerated approval for the third-line treatment of follicular lymphoma.
-
Hengyi 1.2 million tons of caprolactam-polyamide industry integration will start construction within this year
Time of Update: 2022-08-17
△ Qinzhou Port PetroChina Refinery According to the agreement, Hengyi Group will build the “Belt and Road” cross-regional cooperation and ASEAN-oriented high-end green chemical and chemical fiber integration projects in Qinzhou, and build sub-projects such as caprolactam-nylon, PTA-polyester, with a total investment of about 45 billion yuan.
-
Merck's 2021 financial report: Growth hits record high, profitability continues to climb
Time of Update: 2022-04-30
Fiscal 2022 Forecast Strong organic growth in net sales and EBITDA; All business units will make positive contributions; the Life Sciences business will remain the Group's strongest growth engine .
-
Luxi Group participated in the 9th National Petroleum and Chemical Industry Vocational Skills Competition
Time of Update: 2022-02-25
Wang Lin, an employee of Luxi Group Environmental Monitoring Center, won the fourth individual and the honorary title of "National Petroleum and Chemical Industry Technical Expert" in the industrial wastewater treatment competition.
-
Bayer plans a new China strategic planning bureau
Time of Update: 2021-11-17
In addition to the relocation of the headquarters of the subordinate group, in November 2014, Bayer of Germany completed the overall acquisition of China Dianhong Pharmaceutical at a price of 3.
-
Breakthrough in new kerosene co-refining process
Time of Update: 2021-09-19
The project has formed a new kerosene co-refining process by improving industrial demonstration equipment and upgrading process technology, realizing a breakthrough in the technical bottleneck of the deep conversion of heavy oil and coal hydrogenation to gasoline and diesel, and providing a new technology for heavy oil processing and high-efficiency conversion of coal Route .
-
Working group experts say the situation in Fujian is severe and complicated
Time of Update: 2021-09-18
Working group experts say the situation in Fujian is severe and complicated Working Group Experts Says Fujian's Epidemic Situation is Severe and Complicated Experts from the Nati
-
High-repetition frequency, high-throughput, high-order harmonic ultrafast angle-resolved photoelectron spectrometer was built and applied
Time of Update: 2021-08-28
With the development of ultrafast laser technology, the ultrafast angle-resolved photoelectron spectrometer (TR-ARPES) combined with pump-detection technology can be used to detect non-equilibrium electronic energy band information due to its time resolution capability.
-
J Clin Oncol: Efficacy of vincristine + irinotecan with or without temozolomide in the treatment of relapsed or refractory rhabdomyosarcoma in children and adults: a randomized phase II study
Time of Update: 2021-08-13
Recently, the European research team launched a phase II study VIT-0910 to evaluate the efficacy and safety of vincristine + irinotecan with or without temozolomide in the treatment of relapsed or refractory rhabdomyosarcoma .
-
This year, the number of mobile phone bookings for National Day travel online orders increased by 400 times year-on-year
Time of Update: 2021-05-02
com shows that among the 2014 National Day travel online orders, the number of mobile APP bookings has increased rapidly, an increase of nearly 400 times over the same period last year.
-
Six standards in the field of stem cells guarantee biosafety and ethical norms
Time of Update: 2021-03-26
Committee member China Ke Xueyuan stem cell regeneration research associate with the Institute of Medical Innovation Yao Peng Jin said, the development of biological sample libraries need to pay particular attention to informed consent, privacy and other ethical issues.
-
Yulin seeks the innovation and development of energy and chemical industry
Time of Update: 2020-12-16
On September 13th, a symposium on energy and chemical innovation and development in northern Shaanxi Province was held in Shaolin, Shaanxi Province, inviting experts and scholars from some institution
-
Optimization and Application of the Group I Ribozyme Trans-Splicing Reaction
Time of Update: 2020-12-06
Group I ribozymes are naturally occurring catalytic RNAs that are able to excise themselves as introns (group I introns) from a precursor RNA, and to ligate the flanking exons.
This ribozyme transesterification reaction has potential in molecular biology and in medicine as a new approach to gene therapy.
-
Study: Young children under 5 years of age are more likely than adults to transmit the new coronavirus
Time of Update: 2020-12-02
BEIJING, Aug. 2 (Xinhua) -- Researchers have found that the quality of the new coronavirus gene in the nasal cavity of children under 5 years of age is 10 to 100 times higher than that of adults and older children, meaning that young children may be the main "driver" of the virus's transmission in the community, Singapore's reported.
